Why Blood Pressure Control Matters for Brain Aging
High blood pressure damages the brain's blood vessels and accelerates cognitive decline, but studies show intensive control cuts dementia risk by 13% or more.
Category Diet
Could Blood Tests Create More Demand for Neurologists?
Blood biomarker tests could identify millions with early brain disease, but neurologists are already in short supply.
Could New Diagnostics Expand Treatment Access?
Blood biomarkers and AI are reshaping how patients access treatment, but unequal access threatens to deepen healthcare disparities.
How Mild Cognitive Impairment Fits Into Alzheimer’s Treatment
Mild cognitive impairment is the clinical stage where Alzheimer's treatment works best—a critical window before dementia fully develops.
Why Treatment Eligibility Can Be Narrow
Dementia treatments have strict eligibility rules because medications work only for specific disease stages and patient profiles. Understanding these limits helps you navigate real-world options.
How Disease Stage Shapes Alzheimer’s Treatment Options
Alzheimer's treatment options change dramatically as the disease progresses, shifting from cognitive preservation in early stages to comfort and behavioral management in late stages.
Why Dementia Wandering Creates Serious Safety Risks
People with dementia wander without understanding danger, making every episode a potential medical emergency.
Could Blood Tests Reduce the Need for Repeated Brain Scans?
Blood tests can track disease progression in diagnosed dementia, but they cannot yet replace initial brain imaging for diagnosis or ruling out other causes.
Why Loneliness Is a Brain Health Concern
Loneliness does measurable damage to the brain: increasing dementia risk by 31% and causing physical shrinkage in memory centers.
Could Blood Tests Create More Demand for Neurologists?
New blood tests for brain disease biomarkers could overwhelm neurology practices unless specialist capacity expands significantly.